We will announce our financial results for the first three months of 2024 at 07:30 CET on 02 May 2024.

We will announce our financial results for the first six months of 2024 at 07:30 CEST on 07 August 2024.

We are pleased to announce our financial results for the first nine months of 2024 at 07:30 CET on 06 November 2024.

Q4 and full-year 2024 financial results will be published in the first two month of 2025. Exact date to be determined.

Our CEO, Lars Fruergaard Jørgensen, presented at the Annual J.P. Morgan Healthcare Conference in San Francisco, USA on 09 January.

Listen to the webcast

Our Capital Markets Day will take place on the 7th of March from 09:00 – 18:00 CET.

Novo Nordisk Executive Management and other members of senior management will provide a full review of our strategy, operations and financial targets. 

The event will be available for all via webcast. The link will be made available here prior to the event.

Our Annual General Meeting (AGM) will take place on 21 March 2024.

Stay tuned for upcoming events scheduled for 2024.

Stay informed

Stay informed

Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.

Please fill in the fields below to receive our news

E-mail address

Email is required Invalid email address
reCAPTCHA verification required

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Annual Report

Cover page of the Novo Nordisk Annual Report 2023

Annual Report 2023

Download Annual Report